Molecular Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention Chemical and Biological Aspects of Inflammation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Breuleux, M.
Right arrow Articles by Eppenberger, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Breuleux, M.
Right arrow Articles by Eppenberger, U.
Molecular Cancer Research 4:27-37 (2006)
© 2006 American Association for Cancer Research


Signaling and Regulation

Heregulins Implicated in Cellular Functions Other Than Receptor Activation

Madlaina Breuleux, Fabrice Schoumacher, Daniel Rehn, Willy Küng, Heinz Mueller and Urs Eppenberger

Molecular Tumorbiology Unit, Department of Research, Stiftung Tumorbank and University Clinics Medical School, Basel, Switzerland

Requests for reprints: Madlaina Breuleux, Novartis Pharma AG, Klybeckstrasse 125, WKL-125.12.59, 4002 Basel, Switzerland. Phone: 41-61-696-25-17; Fax: 41-61-696-63-81. E-mail: madlaina.breuleux{at}novartis.com

Heregulins (HRG) are known as soluble secreted growth factors that, on binding and activating ErbB3 and ErbB4 cell surface receptors, are involved in cell proliferation, metastasis, survival, and differentiation in normal and malignant tissues. Previous studies have shown that some HRG1 splice variants are translocated to the nucleus. By investigating the subcellular localization of HRG{alpha}1-241, nuclear translocation and accumulation in nuclear dot-like structures was shown in breast cancer cells. This subcellular distribution pattern depends on the presence of at least one of two nuclear localization sequences and on two domains on the HRG construct that were found to be necessary for nuclear dot formation. Focusing on the nuclear function of HRG, a mammary gland cDNA library was screened with the mature form of HRG{alpha} in a yeast two-hybrid system, and coimmunoprecipitation of endogenous HRG was done. The data reveal positive interactions of HRG{alpha}1-241 with nuclear factors implicated in different biological functions, including transcriptional control as exemplified by interaction with the transcriptional repressor histone deacetylase 2. In addition, HRG{alpha}1-241 showed transcriptional repression activity in a reporter gene assay. Furthermore, a potential of HRG proteins to form homodimers was reported and the HRG sequence responsible for dimerization was identified. These observations strongly support the notion that HRG1 splice variants have multifunctional properties, including previously unknown regulatory functions within the nucleus that are different from the activation of ErbB receptor signaling. (Mol Cancer Res 2006;4(1):27–37)




This article has been cited by other articles:


Home page
Am J Health Syst PharmHome page
S. Goodin
Development of monoclonal antibodies for the treatment of colorectal cancer
Am. J. Health Syst. Pharm., June 1, 2008; 65(11_Supplement_4): S3 - S7.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. V.L. Hayes, E. Blackburn, L. V. Smart, M. M. Boyle, G. A. Russell, T. M. Frost, B. J.T. Morgan, A. J. Baines, and W. J. Gullick
Identification and Characterization of Novel Spliced Variants of Neuregulin 4 in Prostate Cancer
Clin. Cancer Res., June 1, 2007; 13(11): 3147 - 3155.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.